Summary
Endo International Plc (Endo) is a specialty healthcare company that develops, manufactures and commercializes various branded pharmaceutical products, generic pharmaceuticals and other products through its operating companies including Endo Pharmaceuticals, Paladin Labs, Par Pharmaceutical, Litha and SOMAR. It sells generic products principally in the US across multiple therapeutic categories, comprising urology, pain management, central nervous system (CNS) disorders, immunosuppression, cancer, cardiovascular diseases and women’s health markets, among others. The company's branded pharmaceuticals target urology, orthopedics/pediatric endocrinology and pain management markets. Endo also provides over-the-counter (OTC) products across key market segments comprising dermatology and anti-infectives. The company sells its products through independent wholesale distributors, as well as to retailers, government agencies, doctors, clinics, independent retail and specialty pharmacies and independent specialty distributors. Endo is headquartered in Dublin, Ireland.
Endo International Plc (ENDP) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Endo International Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Endo International Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Endo International Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Endo International Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Endo International Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Endo International Plc, Medical Equipment, Deal Details 11
Private Equity 11
Altaris Capital Partners Completes Acquisition Of HealthTronics From Endo Health Solutions For US$130 Million 11
Partnerships 12
Trendlines Enters Into Co-Development Agreement With Endo Health Solutions For Urology And Pain Devices 12
Litha Pharma Partners with Gland Pharma 13
Debt Offering 13
Auxilium Pharma Completes Public Offering Of Notes Due 2018 For US$350 Million 13
Endo Pharma Completes Private Placement Of Senior Unsecured Notes Due 2022 For US$400 Million 14
Endo Pharma Completes Private Placement Of Senior Unsecured Notes Due 2019 For US$500 Million 15
Asset Transactions 17
Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 17
Trendlines Acquires Intellectual Property from Endo 17
Acquisition 18
Par Pharma Acquires Innoteq for USD27 Million 18
Paladin Labs to Acquire Remaining 32.5% Stake in Litha Healthcare for USD41 Million 19
Endo Health Solutions Completes Acquisition Of Paladin Labs For US$1.6 Billion 20
Par Pharma Acquires JHP Group for USD488 Million 23
Paladin Labs Completes Acquisition Of Additional 5.97% Stake In Litha Healthcare 24
Paladin Labs Completes Acquisition Of Majority Stake In Ativa Pharma 25
Paladin Labs Completes Acquisition Of 44.52% Stake In Litha Healthcare Group For US$26.2 Million 25
Endo Pharma Acquires American Medical Systems 26
Endo Pharma To Acquire A Pharma Company 28
Endo International Plc - Key Competitors 30
Key Employees 31
Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 35
Financial Announcements 35
Feb 28, 2017: Endo Reports Fourth-Quarter And Full-Year 2016 Financial Results 35
Nov 08, 2016: Endo Reports Third Quarter 2016 Financial Results 38
Aug 08, 2016: Endo Reports Second Quarter 2016 Financial Results 40
May 05, 2016: Endo Reports First Quarter 2016 Financial Results 42
Feb 29, 2016: Endo Reports Fourth Quarter And Full Year 2015 Financial Results 44
Corporate Communications 46
Dec 21, 2016: Endo Announces Appointments and Updates to Executive Management Team 46
Dec 20, 2016: Endo Announces Appointment of Blaise Coleman as Chief Financial Officer 47
Nov 07, 2016: Endo Strengthens Leadership Team with Appointment of Two Key Executives 48
Oct 20, 2016: Endo Announces Departure of Chief Financial Officer 49
Sep 23, 2016: Endo Names Paul Campanelli President and Chief Executive Officer 50
Aug 08, 2016: Endo Announces Appointment of Joseph J. Ciaffoni as President, U.S. Branded Pharmaceuticals 51
May 05, 2016: Endo Announces Appointment of Douglas S. Ingram and Todd B. Sisitsky to its Board of Directors 52
May 05, 2016: Endo Announces Change to Senior Management Team 53
Product News 54
01/26/2016: NICE consults on plans to support new device for treating enlarged prostate glands 54
Other Significant Developments 55
Jan 26, 2017: Endo Announces Actions to Drive Greater Efficiency and Business Alignment 55
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56
List of Tables
Endo International Plc, Medical Equipment, Key Facts, 2016 1
Endo International Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Endo International Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Endo International Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Endo International Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Endo International Plc, Deals By Market, 2011 to YTD 2017 9
Endo International Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Altaris Capital Partners Completes Acquisition Of HealthTronics From Endo Health Solutions For US$130 Million 11
Trendlines Enters Into Co-Development Agreement With Endo Health Solutions For Urology And Pain Devices 12
Litha Pharma Partners with Gland Pharma 13
Auxilium Pharma Completes Public Offering Of Notes Due 2018 For US$350 Million 13
Endo Pharma Completes Private Placement Of Senior Unsecured Notes Due 2022 For US$400 Million 14
Endo Pharma Completes Private Placement Of Senior Unsecured Notes Due 2019 For US$500 Million 15
Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 17
Trendlines Acquires Intellectual Property from Endo 17
Par Pharma Acquires Innoteq for USD27 Million 18
Paladin Labs to Acquire Remaining 32.5% Stake in Litha Healthcare for USD41 Million 19
Endo Health Solutions Completes Acquisition Of Paladin Labs For US$1.6 Billion 20
Par Pharma Acquires JHP Group for USD488 Million 23
Paladin Labs Completes Acquisition Of Additional 5.97% Stake In Litha Healthcare 24
Paladin Labs Completes Acquisition Of Majority Stake In Ativa Pharma 25
Paladin Labs Completes Acquisition Of 44.52% Stake In Litha Healthcare Group For US$26.2 Million 25
Endo Pharma Acquires American Medical Systems 26
Endo Pharma To Acquire A Pharma Company 28
Endo International Plc, Key Competitors 30
Endo International Plc, Key Employees 31
Endo International Plc, Other Locations 33
Endo International Plc, Subsidiaries 33
List of Figures
Endo International Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Endo International Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Endo International Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Endo International Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Endo International Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Endo International Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
Endo International Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Endo International Plc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9
